Sarcoidosis extent relates to molecular variability (original) (raw)

Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes

Michael Y Li

The European respiratory journal, 2014

View PDFchevron_right

Linkage of Type I Interferon Activity and TNF-Alpha Levels in Serum with Sarcoidosis Manifestations and Ancestry

Timothy Niewold

PLoS ONE, 2011

View PDFchevron_right

Interferon-inducible chemokines reflect severity and progression in sarcoidosis

Joris Ramstein

Respiratory Research, 2013

View PDFchevron_right

Phenotypes of organ involvement in sarcoidosis

Martina Vašáková

The European respiratory journal, 2018

View PDFchevron_right

Identification of key regulators in Sarcoidosis through multidimensional systems biological approach

Md Zubbair Malik

Scientific Reports, 2022

View PDFchevron_right

Serum level of soluble tumour necrosis factor receptor II (75 kDa) indicates inflammatory activity of sarcoidosis

Nadine Martinet, Joachim Muller-quernheim

Journal of Internal Medicine, 2000

View PDFchevron_right

Genetic, Immunologic, and Environmental Basis of Sarcoidosis

Courtney Montgomery

Annals of the American Thoracic Society, 2017

View PDFchevron_right

Disease marker combination enhances patient characterization in the Finnish sarcoidosis patients

Olof Selroos

Respiratory Medicine, 2017

View PDFchevron_right

Hypothesis: Sarcoidosis is a STAT1-mediated disease

Stephen Planck

Clinical Immunology, 2009

View PDFchevron_right

The evidence for biologic immunotherapy in Sarcoidosis: A systematic review

Pooja Shah

Australasian Medical Journal, 2017

View PDFchevron_right

The Burden of Comorbidity and Complexity in Sarcoidosis: Impact of Associated Chronic Diseases

Fernanda Hernández

Lung, 2017

View PDFchevron_right

Personalized prognosis of sarcoidosis based on the complex analysis of possible aetiological agents and mechanisms of immunopathogenesis

Ольга Орлова

2019

View PDFchevron_right

Sarcoidosis: is there a role for anti-TNF-α?

Marjolein Drent

Revista Portuguesa de Pneumologia, 2007

View PDFchevron_right

Association of the TNF- G-308A polymorphism with TNF-inhibitor response in sarcoidosis

Marjolein Drent

European Respiratory Journal, 2014

View PDFchevron_right

Disease Burden and Variability in Sarcoidosis

Yvette Cozier

Annals of the American Thoracic Society, 2017

View PDFchevron_right

Vascular endothelial growth factor and tumor necrosis factor genes polymorphisms in Turkish patients with sarcoidosis

Zeki Gunlu

PubMed, 2008

View PDFchevron_right

Low Levels of NF- B/p65 Mark Anergic CD4+ T Cells and Correlate with Disease Severity in Sarcoidosis

Marc Judson

Clinical and Vaccine Immunology, 2011

View PDFchevron_right

Design of A Case Control Etiologic Study of Sarcoidosis (ACCESS)

Lee Newman

Journal of Clinical Epidemiology, 1999

View PDFchevron_right

Tumor Necrosis Factor Gene Polymorphisms in Turkish Patients with Sarcoidosis

Zeki Gunlu

Internal Medicine, 2008

View PDFchevron_right

Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis

L. Pallarés

Expert Review of Clinical Immunology, 2019

View PDFchevron_right

In Clinically and Genetically Defined Subgroups of Patients with Pulmonary Sarcoidosis

Farah Idali

2008

View PDFchevron_right

Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis

Carlo Albera

The European respiratory journal, 2014

View PDFchevron_right

Significant CD4, CD8, and CD19 Lymphopenia in Peripheral Blood of Sarcoidosis Patients Correlates with Severe Disease Manifestations

David Pitrak

PLoS ONE, 2010

View PDFchevron_right

Practical eminence and experience-based recommendations for use of TNF-α inhibitors in sarcoidosis

Marjolein Drent

Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2014

View PDFchevron_right

Clinical, imaging and functional determinants of sarcoidosis phenotypes in a Greek population

Evangelia Fouka

Journal of Thoracic Disease

View PDFchevron_right

Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis

Lee Newman

American Journal of Respiratory and Critical Care Medicine, 2001

View PDFchevron_right

Risk Indicators of Sarcoidosis Evolution-Unified Protocol (RISE-UP): protocol for a multi-centre, longitudinal, observational study to identify clinical features that are predictive of sarcoidosis progression

Lobelia Samavati

BMJ Open, 2023

View PDFchevron_right

Genome-wide association analysis reveals 12q13.3-q14.1 as new risk locus for sarcoidosis

Frantisek Mrazek

European Respiratory Journal, 2013

View PDFchevron_right

Genes and metabolic pathway of sarcoidosis: identification of key players and risk modifiers

Milena Santric-milicevic

Archives of Medical Science

View PDFchevron_right